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Expression of NCS-1 (neuronal calcium sensor-1, also
termed frequenin) in 3T3L1 adipocytes strongly inhib-
ited insulin-stimulated translocation of GLUT4 and in-
sulin-responsive aminopeptidase. The effect of NCS-1
was specific for GLUT4 and the insulin-responsive ami-
nopeptidase translocation as there was no effect on the
trafficking of the cation-independent mannose 6-phos-
phate receptor or the GLUT1 glucose transporter iso-
form. Moreover, NCS-1 showed partial colocalization
with GLUT4-EGFP in the perinuclear region. The inhib-
itory action of NCS-1 was independent of calcium se-
questration since neither treatment with ionomycin
nor endothelin-1, both of which elevated the intracellu-
lar calcium concentration, restored insulin-stimulated
GLUT4 translocation. Furthermore, NCS-1 did not alter
the insulin-stimulated protein kinase B (PKB/Akt) phos-
phorylation or the recruitment of Cbl to the plasma
membrane. In contrast, expression of the NCS-1 effector
phosphatidylinositol 4-kinase (PI 4-kinase) inhibited in-
sulin-stimulated GLUT4 translocation, whereas co-
transfection with an inactive PI 4-kinase mutant pre-
vented the NCS-1-induced inhibition. These data
demonstrate that PI 4-kinase functions to negatively
regulate GLUT4 translocation through its interaction
with NCS-1.
Neuronal calcium sensor 1 (NCS-1)1 is one member of a large
family of calcium-binding proteins that includes frequenin, re-
coverin, guanylate cyclase-activating proteins, neurocalcin,
and visinin (1–4). This family of proteins has been linked to the
regulation of various intracellular events including phototrans-
duction, neurotransmitter release, control of cyclic nucleotide
metabolism, gene expression, ion channels function, and phos-
phoinositide metabolism. For example, Drosophila mutants
overexpressing frequenin display a frequency-dependent facil-
itation of neurotransmitter release at the neuromuscular junc-
tion (5). Similarly, overexpression of frequenin in PC12 cells
potentiates agonist (ATP)-stimulated secretion of growth hor-
mone (6). These data suggest that NCS-1/frequenin may func-
tion as a positive regulator of vesicle exocytosis. However, a
negative role for NCS-1 was observed in Madin-Darby canine
kidney cells, where overexpression of NCS-1 inhibited apical
membrane transport without affecting trafficking to the baso-
lateral membrane (7).
Recently the yeast homologue of frequenin (Frq1p) was re-
ported to function as a calcium-sensing subunit of Pik1p, a
phosphatidylinositol 4-kinase (8). Pik1p is an essential enzyme
necessary for normal secretion, Golgi membrane traffic, and
vacuole membrane dynamics and endocytosis in yeast (9, 10).
In these cells, Pik1p mutants exhibit severe protein trafficking
defects and accumulate morphologically aberrant Golgi mem-
branes (9, 11). In mammalian cells, NCS-1 directly interacts
with the phosphatidylinositol 4-kinase  isoform, the human
homologue of yeast Pik1p (12). Furthermore, the binding of
NCS-1 stimulates the lipid kinase activity of phosphatidyl-
inositol (PI) 4-kinase  (13).
Previously, it was observed that highly purified GLUT4-
containing vesicles from both rat adipocytes and skeletal mus-
cle were highly enriched for PI 4-kinase activity (14, 15). Be-
cause NCS-1 appears to function as a regulatory subunit of the
PI 4-kinase and has been implicated in the control of several
membrane transport processes, we have examined the function
of NCS-1 in the regulation of insulin-stimulated GLUT4 trans-
location. In this study, we demonstrate that overexpression of
NCS-1 in 3T3L1 adipocytes inhibits GLUT4 translocation
through its interaction with PI 4-kinase .
EXPERIMENTAL PROCEDURES
Materials—Insulin, endothelin-1, dexamethasone, and 3-isobutyl-2-
methylxantine were obtained from Sigma. Ionomycin (free acid) was
obtained from Calbiochem. The PI 4-kinase  antibody was purchased
from Upstate Biotechnology, and the NCS-1 antibody was prepared as
previously described (16). Akt and the phosphoserine 473-specific Akt
antibodies were purchased from New England Biolabs. The HA antibody
(SC-7392) was obtained from Santa Cruz Biotechnology, and fluorescent
secondary antibodies were purchased from Jackson Immunoresearch
Laboratories. Horseradish peroxidase-conjugated antibodies and en-
hanced chemiluminescence reagents were obtained from Pierce.
Tissue Culture and Transient Transfection of 3T3L1 Adipocytes—
Murine 3T3L1 preadipocytes were purchased from American Type Tis-
sue Culture repository. Cells were cultured at 37 °C and 8% CO2 in
Dulbecco’s modified Eagle’s medium supplemented with 25 mM glucose,
10% bovine calf serum containing penicillin and streptomycin. Cells
were differentiated into adipocytes with 1 g/ml insulin, 1 M dexa-
methasone, and 0.5 mM 3-isobutyl-1-methylxanthine as described pre-
viously (17). Fully differentiated 3T3L1 adipocytes were transfected by
low voltage (0.15 V at 960 F) as previously described (18). After
electroporation, the cells were plated on collagen IV-coated glass cov-
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erslips and allowed to recover for 20–32 h in complete medium before
analysis.
Immunofluorescence—The cells were incubated at 37 °C for 2 h in
Dulbecco’s modified Eagle’s medium without serum and then either left
untreated or stimulated with 100 nM insulin for 30 min. The cells were
washed once with ice-cold phosphate-buffered saline and fixed/perme-
abilized with a solution containing 4% paraformaldehyde and 0.2%
Triton X-100 for 15 min at room temperature. The samples were then
washed with phosphate-buffered saline and blocked with a solution
containing 1% bovine serum albumin and 5% donkey serum for 1 h at
room temperature, and primary antibodies (1:50 for NCS-1 and 1:100
dilution for PI 4-kinase ) were added for 1 h at room temperature. The
samples were again washed with phosphate-buffered saline, incubated
with a secondary antibody conjugated to Texas Red (1:100 dilution) for
1 h, and washed, and the coverslips were mounted on Vectashield for
visualization using a Zeiss LSM510 confocal microscope.
Calcium Measurements—Intracellular Ca2 levels were measured
using a video microscope digital image analysis system (Photon Tech-
nology International, Inc., South Brunswick, NJ) as described previ-
ously (19). Briefly, differentiated 3T3L1 cells were placed in serum-free
Dulbecco’s modified Eagle’s medium supplemented with 30 mM Hepes,
pH 7.0, and 0.2% bovine serum albumin for 2 h. FURA02 (Molecular
Probes Inc, Eugene, OR) was added to the cells (1 M) for 30 min at
37 °C, and the cells were then washed 3 times with Dulbecco’s modified
Eagle’s medium and incubated an additional 20–30 min before meas-
urement of Ca2 levels. Basal readings were determined before stimu-
lation with either insulin (100 nM), endothelin (100 nM), or ionomycin (1
M) and recorded at 37 °C every 10 s over a 15–20-min time range.
Immunoprecipitation and Western Blot Analysis—After transfection
of the differentiated 3T3L1 adipocytes, whole cell extracts were pre-
pared by scraping the cells in lysis buffer (25 mM Hepes, pH 7.5, 1%
Nonidet P-40, 5% glycerol, 130 mM NaCl, 50 mM NaF, 10 mM Na2HP2O4,
1 mM sodium vanadate, 1 mM phenylmethylsulfonyl fluoride, 10 g/ml
aprotinin, 1 g/ml leupeptin, and 1 g/ml pepstatin). Protein content in
the extracts was assayed by the BCA method (Pierce), and for immu-
noprecipitation, 400 g of protein were incubated with 6 g of the HA
FIG. 1. NCS-1 inhibits GLUT4-EGFP
insulin-induced translocation to the
plasma membrane but not mannose
6-phosphate-EGFP. A, cells were elec-
troporated with 50 g of GLUT4-EGFP
and 200 g of NCS-1 plasmid or 50 g of
mannose 6-phosphate receptor (M6PR)-
EGFP with 200 g of NCS-1 plasmid as
described under “Experimental Proce-
dures.” Twenty-four h after transfection,
cells were serum-starved and stimulated
with 100 nM insulin at 37 °C for 30 min,
washed, and fixed as described under “Ex-
perimental Procedures.” The images
shown are representative of several ex-
periments in cells co-expressing NCS-1
and GLUT4-EGFP. B, quantification of
cell surface fluorescence after insulin
stimulation of cells expressing GLUT4-
EGFP and empty vector or GLUT4-EGFP
with NCS-1. These data represent the av-
erage values  S.D. from at least three
independent experiments. C, cells were
electroporated with 50 g of GLUT1-
EGFP and 200 g of either empty vector
or plasmid coding for NCS-1, as described
under “Experimental Procedures.” Twen-
ty-four hours after transfection, cells were
serum-starved and stimulated with 100
nM insulin at 37 °C for 30 min, washed,
and fixed as described under “Experimen-
tal Procedures.”
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antibody coupled to goat anti-mouse IgG-agarose beads or with 8 g of
the NCS-1 polyclonal antibody coupled to protein A beads. For Western
blotting 6 g of protein were separated by SDS-PAGE. After immuno-
precipitation and SDS-polyacrylamide gel electrophoresis, the samples
were then transferred to nitrocellulose membrane and immunoblotted
for NCS-1, PI 4-kinase, GLUT4, caveolin-1, and flotillin.
RESULTS
Overexpression of NCS-1 Inhibits Insulin-stimulated GLUT4
Translocation in 3T3L1 Adipocytes—To examine the potential
effect of NCS-1 on insulin-stimulated GLUT4 translocation, we
co-transfected 3T3L1 adipocytes with NCS-1 and a GLUT4-
EGFP fusion reporter protein or with GLUT4-EGFP plus an
empty vector (Fig. 1A). As typically observed, cells that were
transfected with GLUT4-EGFP and an empty vector exhibited
a robust translocation of GLUT4-EGFP from intracellular stor-
age sites to the plasma membrane upon insulin stimulation
(Fig. 1A, panels a and b). Although expression of NCS-1 had no
significant affect on the intracellular localization of GLUT4-
EGFP in the basal state, there was a marked inhibition of
insulin-stimulated GLUT4-EGFP translocation to the plasma
membrane (Fig. 1A, panels c and d). Quantitation of the num-
ber of cells displaying a plasma membrane rim fluorescence
indicated that in the empty vector transfected cells, insulin-
stimulated GLUT4 translocation from 15% to greater than
60% (Fig. 1B). In contrast, NCS-1 expression had no significant
affect in the basal state but reduced the number of cells
displaying insulin-stimulated GLUT4 translocation to 25%
(Fig. 1B).
The insulin-responsive aminopeptidase is another marker
for insulin-responsive vesicular compartments, as this protein
co-localizes with GLUT4 and undergoes a nearly identical pat-
tern of insulin-stimulated plasma membrane translocation
(20–22). Similar to GLUT4, expression of NCS-1 also inhibited
the insulin-stimulated translocation of insulin-responsive
aminopeptidase to the plasma membrane (data not shown).
The cation-independent mannose 6-phosphate/insulin-like
growth factor-2 receptor is localized to compartments distinct
from GLUT4 and insulin-responsive aminopeptidase but can
also undergo an insulin-stimulated translocation to the plasma
membrane (23, 24) (Fig. 1A, panels e and f). The ability of
insulin to simulate cation-independent mannose 6-phosphate
receptor plasma membrane translocation was also not signifi-
cantly affected by the co-expression of NCS-1 (Fig. 1A, panels g
and h). Furthermore, the co-expression of NCS-1 with GLUT1-
EGFP did not prevent its normal basal state (data not shown)
or insulin-stimulated trafficking to the plasma membrane (Fig.
1C). Together, these data demonstrate that NCS-1 overexpres-
sion inhibits the insulin-stimulated translocation of GLUT4-
FIG. 2. Ionomycin and endothelin-1
but not insulin increase intracellular
calcium in 3T3L1 adipocytes. A, cells
were loaded with FURA02 as described
under “Experimental Procedures.” Basal
calcium content was taken and averaged
for several cells, then cells were stimu-
lated with 100 nM endothelin-1, 100 nM
insulin, or 1 M ionomycin, and calcium
measurements were obtained at different
times. The arrows indicate the time of the
stimulation. B, cells were transfected
with either GLUT4-EGFP (50 g) and
empty vector (200 g) or GLUT4-EGFP
(50 g) and NCS-1 (200 g) as described
under “Experimental Procedures.” Cells
were serum-starved for 2 h before stimu-
lation with 100 nM insulin alone or insulin
and endothelin-1 (100 nM). Cells were
subsequently washed and fixed as de-
scribed under “Experimental Proce-
dures.” Only cells positive for both
GLUT4-EGFP and NCS-1 were examined
for their responsiveness to hormone
treatment.
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containing vesicles but not other insulin-responsive intracellu-
lar compartments or constitutive plasma membrane protein
transport. Thus, we conclude that the effect of NCS-1 was
relatively specific for GLUT4/insulin-responsive aminopepti-
dase compartments.
NCS-1 Inhibition of GLUT4 Translocation Is Specific for
Insulin and Is Not Mediated through Chelation of Intracellular
Calcium—Although calcium is not a mediator of insulin-stim-
ulated GLUT4 translocation or glucose uptake, intracellular
calcium levels are permissive because very low levels or very
high levels prevent insulin action (25, 26). More recently, cal-
modulin inhibitors and chelation of intracellular calcium have
been shown to block insulin-stimulated GLUT4 translocation
and glucose uptake in 3T3L1 adipocytes (27–29). Because
NCS-1 contains four EF-hand domains that can bind calcium,
it was possible that the inhibition of insulin-stimulated GLUT4
translocation was due to the chelation intracellular calcium. To
test this possibility, we first examined the ability of insulin,
endothelin-1, and the calcium ionophore ionomycin to increase
calcium levels in 3T3L1 adipocytes. As expected, insulin treat-
ment had no significant effect on the steady-state calcium
levels in adipocytes (Fig. 2A). In contrast, endothelin-1 stimu-
lation resulted in a transient increase in intracellular calcium
that also occurred in the presence of insulin. Treatment with
ionomycin not only induced a larger increase in intracellular
calcium levels but was persistent throughout the entire time
course examined.
Having established that both endothelin-1 and ionomycin
treatment result in increased cytosolic calcium in 3T3L1 adi-
pocytes, we next examined the effect of NCS-1 under these
conditions (Fig. 2B). As previously observed, insulin treatment
resulted in the translocation of the GLUT4-EGFP reporter
protein that was markedly inhibited upon co-expression with
NCS-1 (Fig. 2B, panels a, b, e, and f). Endothelin-1 also has
been reported to induce the translocation of GLUT4, but to a
substantially reduced extent compared with insulin (30, 31).
Similarly, we observed a small effect of endothelin-1 on the
subcellular redistribution of GLUT4-EGFP that was unaf-
fected by expression of NCS-1 (Fig. 2B, panels c and g). Fur-
thermore, pretreatment of the adipocytes with endothelin-1
followed by insulin also induced GLUT4-EGFP translocation to
a similar extent as insulin stimulation alone (Fig. 2B, panel d).
However, in the presence of NCS-1, pretreatment with endo-
thelin-1 followed by insulin was unable to rescue the insulin-
stimulated extent of GLUT4-EGFP translocation, whereas the
extent of endothelin-1 stimulation remained intact (Fig. 2B,
panel h).
It remained formally possible that the inability of endothe-
lin-1 to rescue insulin-stimulated GLUT4 translocation could
have been due to the transient nature of intracellular calcium
increase under these conditions. To address this issue, we
utilized ionomycin to induce a persistent increase in intracel-
lular calcium levels (Fig. 3). Pretreatment with ionomycin had
no significant effect on either the basal or insulin-stimulated
translocation of GLUT4-EGFP (Fig. 3, panels a–f). As was the
case for endothelin-1, ionomycin was unable to restore insulin-
stimulated GLUT4-EGFP translocation in cells expressing
NCS-1 despite the persistent elevation in intracellular calcium
(Fig. 3, panels g–l). Thus, these data indicate that the inhibi-
tory actions of NCS-1 are probably not due to the chelation of
intracellular calcium.
NCS-1 Does Not Alter Insulin-stimulated Akt Activation or
Plasma Membrane Recruitment of Cbl—To determine whether
NCS-1 blocked GLUT4 translocation by interfering with insu-
lin signaling pathways, we first examined the effect of NCS-1
expression on the insulin-stimulated phosphorylation of Akt
(Fig. 4). HA-Akt-transfected adipocytes displayed Akt expres-
sion, as seen by an Akt immunoblot in total cell extracts (Fig.
4A, lanes 1 and 2). Similarly, cells cotransfected with HA-Akt
and NCS-1 also displayed expression of both HA-Akt and
NCS-1 (Fig. 4A, lanes 3 and 4). The reduced expression of
HA-Akt in cells co-expressing NCS-1 was consistently observed
and probably reflects competition of exogenous gene expression
between these two plasmids. In any case, normalized cell ex-
tracts were immunoprecipitated with the HA antibody and
examined for serine 473 phosphorylation as an indicator of Akt
activation (Fig. 4B). As is readily apparent, insulin was equally
effective in stimulating the serine phosphorylation of Akt both
in the absence and presence of NCS-1 overexpression (Fig. 4B,
lanes 1–4). Furthermore, NCS-1 had no significant effect on the
insulin stimulation of phosphatidylinositol 3,4,5-trisphosphate
formation as assessed by the plasma membrane recruitment of
a EGFP-PH/Grp-1 fusion protein (data not shown). These data
demonstrate that NCS-1 does not affect the insulin stimulation
of insulin receptor substrate/phosphatidylinositol 3-kinase/Akt
pathway.
It has been recently reported that CAP, Cbl, and the small
GTPase TC10 define a second insulin-signaling pathway re-
quired for GLUT4 translocation to the plasma membrane (32–
34). We next tested the effect of NCS-1 expression on this
signaling pathway by monitoring Cbl recruitment to the cell
surface in response to insulin. Twenty-four hours after co-
transfection with HA-Cbl and NCS-1, cells were serum-starved
for 2 h, insulin-stimulated, then washed and fixed as described
under “Experimental Procedures.” As expected in HA-Cbl and
vector-transfected cells, insulin stimulated the redistribution
of HA-Cbl to the plasma membrane (Fig. 5, panels a and b).
Similarly, insulin stimulation of adipocytes expressing NCS-1
had a similar extent of Cbl recruitment to the plasma mem-
brane (Fig. 5, panels c and d). Together these data indicate that
the known insulin-signaling effectors thought to mediate insu-
lin-stimulated GLUT4 translocation were not altered by the
expression of NCS-1.
Expression of PI 4-Kinase Inhibits Insulin-stimulated
FIG. 3. Ionomycin does not rescue
insulin-induced GLUT4-EGFP trans-
location in cells expressing NCS-1.
Cells were transfected with either
GLUT4-EGFP (50 g) and empty vector
(200 g) or GLUT4-EGFP (50 g) and
NCS-1 (200 g) as described under “Ex-
perimental Procedures.” Cells were se-
rum-starved for 2 h before stimulation
with 100 nM insulin or insulin plus iono-
mycin at 0.5 or 1 M. Pictures shown are
representatives of several cells obtained
from at least two independent experi-
ments. Only cells positive for both
GLUT4-EGFP and NCS-1 were examined
for their responsiveness to insulin.
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GLUT4 Translocation—Recently, the yeast homologue of
NCS-1 was shown to activate the lipid kinase activity of pik1p,
the yeast homologue of PI 4-kinase (8). As typically observed,
insulin stimulated the plasma membrane translocation of
GLUT4-EGFP-expressing cells (Fig. 6, panels a and d). Expres-
sion of wild type PI 4-kinase (PI4K/WT) markedly inhibited
insulin-stimulated GLUT4 translocation similar to that of
NCS-1 overexpression (Fig. 6, panels b and e). In contrast,
expression of a kinase-defective PI 4-kinase mutant (PI4K/
MT) had no significant effect on insulin-stimulated GLUT4
translocation (Fig. 6, panels c and f). These results suggest that
the interaction of NCS-1 with the PI 4-kinase is responsible for
the inhibition of insulin-stimulated GLUT4 translocation.
To test this hypothesis, we next co-expressed NCS-1 with
either the wild type or kinase-defective PI 4-kinase (Fig. 7). As
previously observed, co-expression of NCS-1 substantially re-
duced the extent of insulin-stimulated GLUT4 translocation
compared with cells transfected with GLUT4-EGFP alone (Fig.
7, panels b and f). Similarly, co-expression of NCS-1 with the
wild type PI 4-kinase (PI4K/WT) also displayed a reduction in
insulin-stimulated GLUT4-EGFP translocation (Fig. 7, panels
c and g). In any case, co-expression of the kinase-defective PI
4-kinase (PI4K/MT) completely protected the cells from the
NCS-1-induced inhibition of insulin-stimulated GLUT4 trans-
location (Fig. 7, panels d and h). Thus, these data demonstrate
a functional interaction of NCS-1 with PI 4-kinase in 3T3L1
adipocytes.
Localization of NCS-1 and PI 4-Kinase and Expression dur-
ing Adipogenesis—Because increased expression of NCS-1 and
FIG. 4. NCS-1 does not prevent activation of Akt by insulin.
Cells were electroporated with 50 g of HA-Akt and 200 g of either an
empty vector or a plasmid encoding NCS-1 as described under “Exper-
imental Procedures.” Twenty-four hours after electroporation cells were
serum-starved for 2 h, and whole cells lysates were obtained as de-
scribed under “Experimental Procedures.” A, whole cell lysates (50 g)
were loaded as a control for expression of both AKT and NCS-1. B,
whole cell lysates (150 g) were immunoprecipitated (IP) with an HA
antibody, and 1/2 volume of the pellets were separated by SDS-PAGE,
transferred to a nitrocellulose filter, and immunoblotted (IB) with spe-
cific antibodies against Akt or phosphoserine 473-Akt.
FIG. 5. NCS-1 does not inhibit recruitment of Cbl to the plasma
membrane in response to insulin. Cells were electroporated with 50
g of Cbl cDNA and 200 g of either an empty vector or a plasmid
encoding NCS-1 as described under “Experimental Procedures.” Twen-
ty-four hours after transfection cells were serum-starved and then
stimulated with 100 nM insulin, washed, and fixed as described under
“Experimental Procedures.” The photographs shown are representative
cells of two independent experiments.
FIG. 6. Overexpression of wild type phosphatidylinositol 4-ki-
nase but not a kinase-deficient mutant inhibits insulin-stimu-
lated GLUT4-EGFP translocation to the plasma membrane. Cells
were electroporated with 50 g of GLUT4-EGFP and 200 g of either an
empty vector or a plasmid coding for wild type PI 4-kinase (PI4K/WT)
or a plasmid encoding for a PI 4-kinase activity-deficient mutant
(PI4K/MT) as described under “Experimental Procedures.” Twenty-
four hours after transfection, the cells were serum-starved and then
stimulated with 100 nM insulin at 37 °C for 30 min, washed, and fixed
as described under “Experimental Procedures.” The photographs shown
are representative of two independent experiments from cells co-ex-
pressing GLUT4-EGFP with either wild type PI 4-kinase or PI 4-kinase
activity-deficient mutant.
FIG. 7. Overexpression of the PI 4-kinase mutant but not the
wild type isoform rescues insulin-stimulated GLUT4-EGFP
translocation to the plasma membrane. Cells were electroporated
with 25 g of GLUT4-EGFP and 200 g of empty vector (panels a and
e), 25 g of GLUT4-EGFP and 75 g of NCS-1 (panels b and f), 25 g of
GLUT4-EGFP, 75 g of NCS-1, and 150 g of wild type PI 4-kinase
(PI4K/WT) (panels c and g), or 25 g of GLUT4-EGFP, 75 g of NCS-1,
and 150 g of PI 4-kinase activity-deficient mutant (PI4K/MT) (panels
d and h) as described under “Experimental Procedures.” Twenty-four
hours after transfection cells were serum-starved and then stimulated
with 100 nM insulin at 37 °C for 30 min, washed, and fixed as described
under “Experimental Procedures.” The photographs shown are repre-
sentative of two independent experiments.
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the PI 4-kinase are functionally inhibitory to insulin-stimu-
lated GLUT4 translocation, we next compared the subcellular
localization of the endogenous proteins with GLUT4-EGFP
(Fig. 8). NCS-1 was distributed in small vesicular structures
throughout the cell and in most cells was concentrated in the
perinuclear region that partially colocalized with GLUT4-
EGFP (Fig. 8A, panels a–c). In some cells, NCS-1 also resulted
in a nuclear localization (Fig. 8A, panel d), but this is likely due
to nonspecific labeling by the NCS-1 antibody, as it was not
detected when NCS-1 was overexpressed (data not shown).
Nevertheless, insulin treatment had no significant effect on the
distribution of the endogenous NCS-1 protein, whereas
GLUT4-EGFP displayed the typical plasma membrane trans-
location (Fig. 8A, panels d–f). Similarly, the endogenous PI
4-kinase was also distributed throughout the cell interior in
small vesicular structures as well as in the perinuclear region
with a more pronounced colocalization with GLUT4-EGFP
(Fig. 8B, panels a–c). In addition, insulin had no significant
effect on the localization of the endogenous PI 4-kinase (Fig.
8B, panels d–f).
The colocalization of NCS-1 and the PI 4-kinase with intra-
cellular compartmentalized GLUT4 suggests that adipocytes
have a mechanism to reduce their inhibitory action. We there-
fore examined the relative expression levels of NCS-1 and PI
4-kinase during 3T3L1 adipocyte differentiation (Fig. 9). As
expected, caveolin and GLUT4 expression were markedly up-
regulated during the conversion from pre-adipocytes (fibro-
blasts) to adipocytes, albeit with caveolin induction preceding
GLUT4. On the other hand, the levels of flotillin expression
were not significantly affected during the differentiation proc-
ess. In contrast, both NCS-1 and PI 4-kinase were significantly
down-regulated in parallel with the up-regulation of GLUT4
expression and the acquisition of insulin-responsive GLUT4
translocation. Thus, these data indicate that the reduction of
NCS-1 and PI 4-kinase expression is necessary for adipocytes
to acquire insulin-sensitive GLUT4 trafficking.
DISCUSSION
Recent studies demonstrate a role for NCS-1 in the potenti-
ation of neurotransmitter release and in promoting exocytosis
in adrenal chromaffin cells and PC12 cells (6). These secretory
events are calcium-dependent; however, a role for NCS-1 in
non-calcium-dependent secretion has not yet been examined.
One of the best examples of regulated membrane transport is
the insulin-stimulated translocation of the GLUT4 glucose
transporter in adipocytes (36–39). This transport pathway is
not regulated by changes in intracellular calcium levels but is
dependent upon the insulin-stimulated formation of phosphati-
dylinositol 3,4,5-trisphosphate (22, 40–42).
Our data demonstrated that overexpression of NCS-1 in
differentiated 3T3L1 adipocytes markedly inhibited the insu-
lin-stimulated translocation of GLUT4 from its intracellular
storage site to the plasma membrane. This inhibitory function
appears specific for GLUT4 because the constitutive trafficking
of GLUT1 was unaffected. In addition, insulin can also induce
the plasma membrane translocation of the MP6R from com-
partments distinct from GLUT4 (24, 43). Consistent with a
specific GLUT4 inhibitory function, NCS-1 overexpression had
no effect on the insulin-stimulated translocation of MP6R.
Although calcium does not function as a mediator of insulin-
stimulated GLUT4 translocation, chelation of intracellular cal-
cium with BAPTA or blocking of calmodulin function is inhib-
itory (27, 28). BAPTA appeared to function by preventing the
insulin stimulation of Akt activation that was reversed by
elevation of intracellular calcium by treatment with the cal-
cium ionophore A23187. Because NCS-1 can efficiently bind
calcium, it was formally possible that NCS-1 was functioning
similar to BAPTA. However, the inhibitory effect of NCS-1 was
FIG. 8. Colocalization of the endogenous PI 4-kinase and
NCS-1 with GLUT4-EGFP. Cells were electroporated with 50 g of
GLUT4-EGFP and 24 h later serum-starved and stimulated with 100
nM insulin at 37 °C for 30 min. The cells were then washed, fixed, and
subjected to confocal fluorescent microscopy. A, immunofluorescence of
endogenous NCS-1 (panels a and d) compared with GLUT4-EGFP (pan-
els b and e). The merged images are presented in panels c and f). B,
immunofluorescence of endogenous PI 4-kinase (PI4K; panels a and d)
compared with GLUT4-EGFP (panels b and e). The merged images are
presented in panels c and f).
FIG. 9. Expression of the endogenous NCS-1 and PI 4-kinase
during 3T3L1 adipocyte differentiation. Whole cell lysates were
obtained from 3T3L1 cells after different stages of differentiation as
indicated in the figure. Six g of protein were separated by SDS-PAGE
immunoblotted with specific antibodies for NCS-1, PI 4-kinase 
(PI4K), GLUT4, flotillin, and caveolin. The results shown here are
representative of two independent experiments.
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not reversed by increasing intracellular calcium by either en-
dothelin-1 or ionomycin treatment. Furthermore, NCS-1 ex-
pression had no significant effect on insulin-stimulated Akt
phosphorylation. These results suggested that NCS-1 was not
exerting its effects though a calcium chelation mechanism. In
addition, insulin-stimulated plasma membrane recruitment of
Cbl was unaffected, suggesting that both the phosphatidyli-
nositol 3-kinase and CAP/Cbl insulin-signaling pathways were
functional.
More recently, NCS-1 appears to directly interact with PI
4-kinase  and to activate its lipid kinase activity (13). In this
regard, it has been reported that highly purified intracellular
membrane compartments containing GLUT4 also contain PI
4-kinase activity (14, 15). Consistent with these data, both
NCS-1 and PI 4-kinase partially colocalized with GLUT4. Al-
though a specific role for PI 4-kinase activity in regulating
GLUT4 trafficking has not been established, our data indicate
that overexpression of wild type but not a kinase-defective PI
4-kinase  prevented insulin-stimulated GLUT4 translocation.
These data are consistent with PI 4-kinase activity functioning
as a negative regulatory signal in this process. Moreover, ex-
pression of the kinase-defective PI 4-kinase  restored the
insulin-induced translocation of GLUT4 to the plasma mem-
brane in cells overexpressing NCS-1. Because NCS-1 is a
known activator of PI 4-kinase activity, these data strongly
support a model whereby NCS-1 activation of PI 4-kinase gen-
erates an inhibitory signal specific for the insulin-stimulated
GLUT4 translocation process. This conclusion is supported by
the down-regulation of NCS-1 and PI 4-kinase expression that
accompanies adipocyte differentiation. It remains to be deter-
mined whether or not PI-4 kinase activity prevents sorting of
GLUT4 to its insulin-responsive compartment, exit from this
compartment, or in the translocation process itself.
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